Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Explore which risk parity funds are retirement friendly and fit conservative to balanced retirement goals. A quick guide to evaluating suitability.
27,924 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Lenders unveil data-driven loan terms tied to connected design, procurement, and field data. The move marks the next ...
Rocket Lab stock is catching strong momentum this week. We break down the key drivers behind the rally, what it means...
Starting with $1,000? This guide shows how to identify the ultimate dividend stock with durable payouts, build a smal...
As AI reshapes legal work, professors debate its limits in reasoning. This article examines why lawyers already bette...
A new kind of space stock is building recurring AI-powered intelligence from satellites. This article breaks down the...
Oil is headed for another losing week as traders weigh supply routes and demand signals, but a slowdown in Hormuz tra...
Bitcoin faces renewed volatility as veteran trader Peter Brandt hints at moving BTC into gold, sparking a fresh debat...
Global Payments stunned the market with a strong earnings beat and optimistic guidance, triggering a sharp stock move...
Prediction-market trading on Iran’s leadership surged as tensions flared, but unverified rumors triggered rapid price...
House Democrats introduced the Death Bets Act to outlaw prediction markets tied to war outcomes and fatalities amid o...
Insider moves can ripple through biotech stocks. This piece breaks down recent tarsus pharma stock insider activity, ...